'title': 'appili therapeutics acquires clinical stage antifungal program from fujifilm toyama chemical', 'description': 'halifax, nova scotia business wire imv antibioticdeveloper appili therapeutics acquires ati 2307, a clinical stage antifungal program from fujifilm toyama chemical.', 'content': 'halifax, nova scotia business wire appili therapeutics inc. tsxv apli the company or appili , a publicly traded biopharmaceutical company focused on anti infective drug development, announced today it has signed an agreement with fujifilm toyama chemi 10174 chars '